Health

Results: 6589-6600 of 8108

BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

Bupa welcomes Practice Plus Group to its hospital network

BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer

PR Newswire associated0

J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024)

PK MED Announces FDA Clearance to Initiate Its Clinical Program for PKM-01, for Local Treatment of Gout Flares, Directly by a Phase 2 Trial

IWA Outdoor Classics 2024 Set to Unveil World's First Tactical Thermal Imager

PR Newswire associated0

Zepp Health Unveils Zepp OS 3.5 with Zepp Flow™, Powered by Large Language Model AI, Pioneering the Next Generation of Wearable Intelligence Devices at MWC Barcelona 2024

PR Newswire associated0

After a successful Series B fundraising round from Seoul Clinical Laboratories (Korea), Standard Foods and and AWS cloud services representative GrandTech C.G. Systems (Taiwan), H2U secured over 10 million USD in funds

Curia Appoints Steve Lavezoli as Vice President, Biologics

Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial

Vertex Receives CHMP Positive Opinion for KALYDECO® for the Treatment of Infants With Cystic Fibrosis Ages 1 Month and Older

Celltrion presents new two-year data for subcutaneous infliximab (CT-P13 SC) in inflammatory bowel disease (IBD) at the 19th ECCO Congress